Table 5.
Comparison at the end of follow up between group I vs. group II
| Overall Population | Group I PCS |
Group II MCS-DST |
p-value | |
|---|---|---|---|---|
| N (%) | 64 (100) | 35 (54.6) | 29 (45.4) | - |
| Adjuvant chemotherapy, n (%) | 14 (21.9) | 6 (17.1) | 8 (27.6) | 0.372 |
| Recurrence pattern, n (%) at the end of follow up | ||||
| Local recurrence | 9 (14.1) | 6 (17.1) | 3 (10.3) | 0.494 |
| Distant recurrence | 8 (12.5) | 3 (8.6) | 5 (17.2) | 0.451 |
| Both | 4 (6.3) | 2 (5.7) | 2 (6.9) | 1.000 |
| Median time to recurrence, month (IQR) | 11 (4–19) | 4 (3–9) | 16 (12–20) | 0.085 |
| Median time of follow up, months (IQR) | 14 (6–28) | 12 (6–23) | 19 (7–34) | 0.043 |
| Ileostomy closure at the end of follow up, n (%) | 22 (100) | 11 (100) | 11 (100) | 1.000 |
| Time to ileostomy closure (Months), median ((IQR)) | 3.46 (2.3–4.9) | 3.48 (2.3–4.6) | 3.44 (2.26–7.1) | 0.415 |
| Definitive stoma at the end of follow up | 1 (1.6) | 0 | 1 (3.4) | 0.453 |
| Death at one year | 1 (1.5%) | 1 (2.8%) | 0 | 1.000 |
| Late complications, n (%) at the end of follow up | ||||
| Anastomotic stenosis | 1 (1.6) | 2 (5.7%) | 0 | 0.496 |
Legend: IQR interquartile range, MCS-DST Three-row manual staplers, PCS and two-row power circular staplers